Cover image of the article: Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?

Image Credit:Hepat Mon

Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?

Authors

Claudia Della Corte1, Anna Alisi1, Valerio Nobili2,*
1Unit of Liver Research of Bambino Gesu Children's Hospital, Italy
2Unit of Liver Research of Bambino Gesu Children's Hospital, nobili66@yahoo.it, Italy
*Corresponding Author: Unit of Liver Research of Bambino Gesu Children's Hospital, nobili66@yahoo.it, Italy. Tel: +390-668592243. Fax: +390-668592192. Email: nobili66@yahoo.it

Hepatitis Monthly:Vol. 11, issue 7; 558-559
Published online:Jul 31, 2011
Article type:Letter
Received:Apr 07, 2011
Accepted:Apr 12, 2011
How to Cite:Della Corte C, Alisi A, Nobili V. Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?. Hepat Mon. 2011;11(7):. doi:

Abstract

This article does not have abstract.

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Omid Abedian,
Abolghasem Ajami,
Farshideh Abedian,
Araz Mirabi,
Ali-Reza Khalilian,
Hana Saffar
,et al.

Abedian O, Ajami A, Abedian F, Mirabi A, Khalilian A, et al. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6035

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Michael Adler

Adler M. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(7):. doi:

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Seyed Mohammadmehdi Hosseini Moghaddam

Hosseini Moghaddam SM. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(8):. doi: https://doi.org/10.5812/kowsar.1735143X.770

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Melda Ulusoy,
Gulgun Akkoclu,
Ayhan Gozaydin,
Sukran Kose

Ulusoy M, Akkoclu G, Gozaydin A, Kose S. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2010;10(3):. doi:

31
May
2011
Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?

Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?

Hadi Parsian

Parsian H. Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?. Hepat Mon. 2011;11(5):. doi:

More by these authors

Claudia Della CortePubMedScholar
Anna AlisiPubMedScholar
Valerio NobiliPubMedScholar
Share
Cited by
Metrics